NASDAQ:DYN
Dyne Therapeutics
- Stock
Last Close
28.75
17/05 20:00
Market Cap
1.30B
Beta: 0.24
Volume Today
1.32M
Avg: 383.32K
PE Ratio
−6.54
PFCF: −7.34
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 3M - | 1.47B 48,766.67% | 842M 42.56% | 1.37B 62.23% | 506M 62.96% | |||||||
cost of revenue | 1.15B - | 1.15B 0% | 2.03B 77.12% | 2.28B 12.48% | 2.93B 28.54% | 271K - | 700K 158.30% | 1.09M 55.43% | 3.35M 207.44% | 2.46M 26.43% | ||
gross profit | -1.14B - | 321M 128.11% | -1.19B 469.47% | -915M 22.85% | -2.43B 165.14% | -271K - | -700K 158.30% | -1.09M 55.43% | -3.35M 207.44% | -2.46M 26.43% | ||
selling and marketing expenses | -2.46M - | |||||||||||
general and administrative expenses | 97M - | -97M 200% | 128M 231.96% | 161M 25.78% | 189M 17.39% | 517K 99.73% | 2.79M 438.88% | 13.45M 382.66% | 28.72M 113.56% | 28.20M 1.79% | 31.40M 11.34% | |
selling general and administrative expenses | 97M - | -97M 200% | 128M 231.96% | 161M 25.78% | 189M 17.39% | 517K 99.73% | 2.79M 438.88% | 13.45M 382.66% | 28.72M 113.56% | 28.20M 1.79% | 28.94M 2.61% | |
research and development expenses | 4.28M - | 11.04M 158.06% | 45.20M 309.42% | 121.31M 168.38% | 142.76M 17.68% | 210.76M 47.63% | ||||||
other expenses | -211M - | -21K - | -1.32M 6,200% | -790K 40.29% | -8K 98.99% | 2.86M 35,887.50% | ||||||
cost and expenses | 1.24B - | 837M 32.61% | 2.16B 157.59% | 2.44B 13.27% | 3.12B 27.81% | 4.79M 99.85% | 13.83M 188.34% | 58.65M 324.18% | 150.03M 155.81% | 170.96M 13.96% | 242.16M 41.65% | |
operating expenses | 97M - | -308M 417.53% | 128M 141.56% | 161M 25.78% | 189M 17.39% | 4.79M 97.46% | 13.83M 188.34% | 58.65M 324.18% | 150.03M 155.81% | 170.96M 13.96% | 239.70M 40.21% | |
interest expense | 97M - | 67M 30.93% | 546M 714.93% | 625M 14.47% | 616M 1.44% | 5K 100.00% | 396K - | 2.92M - | ||||
ebitda | 150M - | 292M 94.67% | 736M 152.05% | 106M 85.60% | 949M 795.28% | -4.79M 100.50% | -14.59M 204.74% | -58.65M 302.02% | -148.20M 152.70% | -170.96M 15.36% | -239.70M 40.21% | |
operating income | -318M - | -318M 0% | 64M 120.13% | -640M 1,100% | -412M 35.63% | -4.79M 98.84% | -13.83M 188.34% | -58.65M 324.18% | -150.03M 155.81% | -170.96M 13.96% | -242.16M 41.65% | |
depreciation and amortization | 467M - | 292M 37.47% | 614M 110.27% | 766M 24.76% | 867M 13.19% | 24K 100.00% | -762K 3,275% | 700K 191.86% | 1.82M 160.29% | 1.68M 7.63% | 2.46M 46.23% | |
total other income expenses net | -99M - | 50M 150.51% | -491M 1,082% | -649M 32.18% | -126M 80.59% | -21K 99.98% | -1.03M 4,819.05% | -790K 23.52% | 734K 192.91% | 2.86M 290.05% | 6.22M 117.43% | |
income before tax | -417M - | -268M 35.73% | -427M 59.33% | -1.29B 201.87% | -538M 58.26% | -4.81M 99.11% | -14.86M 208.85% | -59.44M 300.01% | -149.29M 151.18% | -168.10M 12.60% | -235.94M 40.36% | |
income tax expense | -58M - | 117M 301.72% | -474M 505.13% | -45M 90.51% | -610M 1,255.56% | -11K 100.00% | -1.32M 11,927.27% | -700K 47.09% | -8K 98.86% | -2.86M 35,675% | ||
net income | -356M - | -67M 81.18% | 50M 174.63% | -1.24B 2,580% | 76M 106.13% | -4.81M 106.33% | -13.54M 181.36% | -58.74M 333.93% | -149.28M 154.15% | -165.24M 10.69% | -235.94M 42.79% | |
weighted average shs out | 100M - | 126M 26% | 125M 0.79% | 129M 3.20% | 162M 25.58% | 10.32M 93.63% | 45.42M 339.94% | 14.40M 68.31% | 50.90M 253.54% | 51.98M 2.12% | 59.68M 14.83% | |
weighted average shs out dil | 100M - | 126M 26% | 126M 0% | 129M 2.38% | 162M 25.58% | 10.32M 93.63% | 45.42M 339.94% | 14.40M 68.31% | 50.90M 253.54% | 51.98M 2.12% | 59.68M 14.83% | |
eps | -3.56 - | -0.53 85.11% | 0.40 175.47% | -9.61 2,502.50% | 0.47 104.89% | -0.47 200% | -0.30 36.17% | -4.08 1,260.00% | -2.93 28.19% | -3.18 8.53% | -3.95 24.21% | |
epsdiluted | -3.56 - | -0.53 85.11% | 0.40 175.47% | -9.61 2,502.50% | 0.47 104.89% | -0.47 200% | -0.30 36.17% | -4.08 1,260.00% | -2.93 28.19% | -3.18 8.53% | -3.95 24.21% |
All numbers in USD (except ratios and percentages)